
Company valuation, historical trends, and peer comparisons.
According to Sinopharm Group Co. Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 83.69B. This represents a change of -8.70% compared to the average of 91.67B of the last 4 quarters.
The mean historical Enterprise Value of Sinopharm Group Co. Ltd. over the last ten years is 82.72B. The current 83.69B Enterprise Value has changed 1.17% with respect to the historical average. Over the past ten years (40 quarters), SHTDY's Enterprise Value was at its highest in in the June 2023 quarter at 131.09B. The Enterprise Value was at its lowest in in the June 2007 quarter at 0.
Average
82.72B
Median
85.67B
Minimum
67.71B
Maximum
101.53B
Discovering the peaks and valleys of Sinopharm Group Co. Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 24.63%
Maximum Annual Enterprise Value = 101.53B
Minimum Annual Increase = -25.93%
Minimum Annual Enterprise Value = 67.71B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 101.53B | 20.15% |
| 2024 | 84.50B | 24.63% |
| 2023 | 67.80B | -1.80% |
| 2022 | 69.04B | 1.81% |
| 2021 | 67.81B | 0.14% |
| 2020 | 67.71B | -25.93% |
| 2019 | 91.42B | -9.03% |
| 2018 | 100.49B | 11.54% |
| 2017 | 90.10B | 3.74% |
| 2016 | 86.84B | 7.39% |
The current Enterprise Value of Sinopharm Group Co. Ltd. (SHTDY) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
84.61B
5-year avg
78.13B
10-year avg
82.72B
Sinopharm Group Co. Ltd.’s Enterprise Value is greater than Shanghai Pharmaceuticals Holding Co., Ltd (73.75B), greater than BIMI International Medical Inc. (3.12M), greater than 111, Inc. (132.40M), less than McKesson Corporation (129.19B), greater than Cardinal Health, Inc. (65.74B), greater than Cencora, Inc. (73.94B), greater than Henry Schein, Inc. (13.54B), greater than Accendra Health, Inc. (1.79B), less than MediPal Holdings Corporation (401.43B), less than Alfresa Holdings Corporation (284.71B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 73.75B | $5.26B | |
| 3.12M | $1.40K | |
| 132.40M | $25.72M | |
| 129.19B | $124.55B | |
| 65.74B | $60.65B | |
| 73.94B | $67.55B | |
| 13.54B | $9.83B | |
| 1.79B | $21.18M | |
| 401.43B | $4.11B | |
| 284.71B | $2.78B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sinopharm Group Co. Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sinopharm Group Co. Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sinopharm Group Co. Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Sinopharm Group Co. Ltd. (SHTDY)?
What is the 3-year average Enterprise Value for Sinopharm Group Co. Ltd. (SHTDY)?
What is the 5-year average Enterprise Value for Sinopharm Group Co. Ltd. (SHTDY)?
How does the current Enterprise Value for Sinopharm Group Co. Ltd. (SHTDY) compare to its historical average?